Sciences

Bird & Bird Welcomes Charles-Henri Caron as New Partner in Paris, Enhancing Life Sciences Expertise Following 16 Years at Hogan Lovells

by

Paris, France — Charles-Henri Caron has transitioned to Bird & Bird as a partner in its life sciences and healthcare practice, marking a significant career shift after 16 years at Hogan Lovells. His new role officially commenced on September 15. Caron’s move brings a wealth of experience in product liability to his new position. He previously served as counsel within Hogan Lovells’ international life sciences team, where he built a strong reputation for his expertise in handling complex legal issues related to product liability and mass torts. At Bird & Bird, Caron will focus on … Read more

UK Aims to Attract Top Global Talent with New Immigration Strategy, Focuses on AI and Life Sciences

by

Davos, Switzerland – In a significant announcement at the Davos summit, Chancellor Rachel Reeves outlined the UK government’s ambition to revamp its immigration strategies, aiming to attract highly-skilled talents in critical sectors such as artificial intelligence and life sciences. This move is an endeavor to position the UK as a pivotal hub for global expertise and innovation. Chancellor Reeves communicated the plans for a thorough review and restructuring of the current immigration paths for top-tier professionals. Her announcement places a strong emphasis on making the UK an attractive destination for international specialists keen on contributing … Read more

SAVA Investors Called to Spearhead Class Action in Cassava Sciences Securities Fraud Case

by

Investors in Cassava Sciences, Inc., a biopharmaceutical company based in Austin, Texas, have been presented with a potential leadership role in a pending securities fraud lawsuit. The legal action accuses the company of providing misleading information which may have influenced investment decisions adversely. At the heart of the allegations is the claim that Cassava Sciences purportedly engaged in both civil securities fraud and manipulations that artificially inflated the value of its stock. This lawsuit, originating from issues flagging between 2020 and 2022, specifically targets discrepancies and alleged misrepresentations in the company’s development and promotional strategies … Read more

Demarest Advogados Expands Expertise with Strategic Hire from Rabelo Law, Elevating Its Position in Life Sciences and Healthcare

by

São Paulo, Brazil – In a strategic move to enhance its expertise in the healthcare and life sciences sectors, Demarest Advogados, a top-tier Brazilian law firm, has announced the addition of a significant new member to its team. The firm has successfully recruited one of the co-founders of the specialized local boutique Rabelo Law, marking a significant expansion in its legal prowess. This recent acquisition highlights Demarest Advogados’s aggressive growth strategy, as the new hire becomes the 10th lateral recruitment for the firm this year alone. This pattern underscores the firm’s commitment to strengthening its … Read more